BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34157136)

  • 21. Mutational analysis and clinical investigations of medically diagnosed GSD 1a patients from Pakistan.
    Gul B; Firasat S; Shan T; Tehreem R; Afshan K
    PLoS One; 2023; 18(11):e0288965. PubMed ID: 38033126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
    Kim GY; Lee YM; Kwon JH; Cho JH; Pan CJ; Starost MF; Mansfield BC; Chou JY
    Mol Genet Metab; 2017 Mar; 120(3):229-234. PubMed ID: 28096054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.
    Chou JY; Mansfield BC
    Hum Mutat; 2008 Jul; 29(7):921-30. PubMed ID: 18449899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evolutionary approach to optimizing glucose-6-phosphatase-α enzymatic activity for gene therapy of glycogen storage disease type Ia.
    Zhang L; Cho JH; Arnaoutova I; Mansfield BC; Chou JY
    J Inherit Metab Dis; 2019 May; 42(3):470-479. PubMed ID: 30714174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation.
    Matern D; Seydewitz HH; Bali D; Lang C; Chen YT
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S10-9. PubMed ID: 12373566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.
    Kim GY; Lee YM; Cho JH; Pan CJ; Jun HS; Springer DA; Mansfield BC; Chou JY
    Hum Mol Genet; 2015 Sep; 24(18):5115-25. PubMed ID: 26089201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
    Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
    J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational spectrum and identification of five novel mutations in G6PC1 gene from a cohort of Glycogen Storage Disease Type 1a.
    Karthi S; Manimaran P; Varalakshmi P; Ganesh R; Kapoor S; Goyal M; Ashokkumar B
    Gene; 2019 Jun; 700():7-16. PubMed ID: 30890478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization.
    Cangelosi D; Resaz R; Petretto A; Segalerba D; Ognibene M; Raggi F; Mastracci L; Grillo F; Bosco MC; Varesio L; Sica A; Colombo I; Eva A
    J Proteome Res; 2019 Jul; 18(7):2965-2978. PubMed ID: 31173686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T.
    Ito K; Tajima G; Kamisato C; Tsumura M; Iwamoto M; Sekiguchi Y; Numata Y; Watanabe K; Yabe Y; Kanki S; Fujieda Y; Goto K; Sogawa Y; Oitate M; Nagase H; Tsuji S; Nishizawa T; Kakuta M; Masuda T; Onishi Y; Koizumi M; Nakamura H; Okada S; Matsuo M; Takaishi K
    J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37788110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yap signalling regulates ductular reactions in mice with CRISPR/Cas9-induced glycogen storage disease type Ia.
    Xie Y; Hu B; Gao Y; Tang Y; Chen G; Shen J; Jiang Z; Jiang H; Han J; Yan J; Jin L
    Anim Cells Syst (Seoul); 2022; 26(6):300-309. PubMed ID: 36605584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.
    Peeks F; Steunenberg TAH; de Boer F; Rubio-Gozalbo ME; Williams M; Burghard R; Rajas F; Oosterveer MH; Weinstein DA; Derks TGJ
    J Inherit Metab Dis; 2017 Sep; 40(5):695-702. PubMed ID: 28397058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo hepatic lipid quantification using MRS at 7 Tesla in a mouse model of glycogen storage disease type 1a.
    Ramamonjisoa N; Ratiney H; Mutel E; Guillou H; Mithieux G; Pilleul F; Rajas F; Beuf O; Cavassila S
    J Lipid Res; 2013 Jul; 54(7):2010-22. PubMed ID: 23596325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9 genome editing of SLC37A4 gene elucidates the role of molecular markers of endoplasmic reticulum stress and apoptosis in renal involvement in glycogen storage disease type Ib.
    Skakic A; Andjelkovic M; Tosic N; Klaassen K; Djordjevic M; Pavlovic S; Stojiljkovic M
    Gene; 2019 Jun; 703():17-25. PubMed ID: 30951856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
    Monteillet L; Gjorgjieva M; Silva M; Verzieux V; Imikirene L; Duchampt A; Guillou H; Mithieux G; Rajas F
    Mol Metab; 2018 Oct; 16():100-115. PubMed ID: 30100243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver-directed gene therapy for murine glycogen storage disease type Ib.
    Kwon JH; Lee YM; Cho JH; Kim GY; Anduaga J; Starost MF; Mansfield BC; Chou JY
    Hum Mol Genet; 2017 Nov; 26(22):4395-4405. PubMed ID: 28973635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
    Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
    Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
    Sun MS; Pan CJ; Shieh JJ; Ghosh A; Chen LY; Mansfield BC; Ward JM; Byrne BJ; Chou JY
    Hum Mol Genet; 2002 Sep; 11(18):2155-64. PubMed ID: 12189168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of mice with a conditional allele for G6pc.
    Peng WT; Pan CJ; Lee EJ; Westphal H; Chou JY
    Genesis; 2009 Sep; 47(9):590-4. PubMed ID: 19548314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.
    Jarrett KE; Lee C; De Giorgi M; Hurley A; Gillard BK; Doerfler AM; Li A; Pownall HJ; Bao G; Lagor WR
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):1997-2006. PubMed ID: 30026278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.